HINCKLEY, Ohio, Sept. 29, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today it was awarded two contracts by the Navy Medical Research Center (NMRC) under its Omnibus III program. The awards are for the provision resources in support of NMRC, including: providing an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research.
ClinicalRM is one of only five other companies to be awarded contracts in both the Full & Open lot (W911QY-11-D-0051), which consists of 14 awardees, and the Small Business Set-Aside lot (W911QY-11-D-0065), which consists of 12 awardees. The contract ceiling for the 5 year Omnibus II program for all awardees is $497 M. The Omnibus III contract is an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract.
The Omnibus III contract was issued with the intent of facilitating NMRC's mission to conduct R&D across its enterprise, including commands the Navy reports to or supports such as OASD-Health Affairs, JTF, CapMed, and more. Other branches of the Government will be able to use the contract with approval of the Contracting Office.
"We have a history of providing similar basic and applied biomedical and clinical research expertise to other areas of the government and are extremely pleased to be part of this award to extend our support to the Navy. Our company's priority is to improve the health and safety of our warfighters and their families through leading medical research," said Victoria Tifft, founder and CEO of ClinicalRM. Said Tifft, "For 18 years we've proven ourselves as trusted and innovative partners to the U.S. Armed Forces research initiatives, and we look forward to extending that relationship within the Navy Medical Resea
Copyright©2010 PR Newswire.
All rights reserved